Transjugular liver biopsy (TJLB) has an advantage over percutaneous liver biopsy (PLB) in that Glisson's capsule is not penetrated, enabling multiple passes without increasing the risk of complications. A new prospective study shows that TJLB is a safe alternative to PLB for obtaining samples of adequate size and quality to assess liver histology.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
Hepatology International Open Access 01 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cholongitas, E. et al. A systematic review of the quality of liver biopsy specimens. Am. J. Clin. Pathol. 125, 710–721 (2006).
Cholongitas, E., Burroughs, A. K. & Dhillon, A. in Evidence-based Gastroenterology and Hepatology. (eds McDonald, J., Burroughs, A. K., Feagan, B. & Fennerty, M.) 762–770 (Blackwell Publishing Ltd, London, UK, 2010).
Cholongitas, E. et al. Transjugular liver biopsy: how good it is for accurate histological interpretation? Gut 55, 1789–1794 (2006).
Procopet, B. Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients. Eur. J. Gastroenterol. Hepatol. http://dx.doi.org/10.1097/MEG.0b013e328355e2ba.
Vibhakorn, S. et al. A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation. Cardiovasc. Intervent. Radiol. 32, 508–513 (2009).
Colloredo, G., Guido, M., Sonzogni, A. & Leandro, G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 39, 239–244 (2003).
Kalambokis, G. et al. Transjugular liver biopsy—indications, adequacy, quality of specimens, and complications—a systematic review. J. Hepatol. 47, 284–294 (2007).
Crawford, A. R., Lin, X. Z. & Crawford, J. M. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 28, 323–331 (1998).
Burroughs, A. K. & Thalheimer, U. Hepatic venous pressure gradient in 2010: optimal measurement is key. Hepatology 51, 1894–1896 (2010).
Burroughs, A. K. et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 50, 425–427 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cholongitas, E., Burroughs, A. Transjugular liver biopsy yields high-quality samples. Nat Rev Gastroenterol Hepatol 9, 491–492 (2012). https://doi.org/10.1038/nrgastro.2012.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2012.146